Methodology, XLZ, QYR, QXY, JWZ, and YJR
Beyond FSP1 there are therapeutic opportunities across the CoQ 10 oxidoreductase network While FSP1 currently has the strongest targetability signal, other CoQ 10 oxidoreductases may be therapeutically leveraged in defined genetic, metabolic or tissue contexts: (1) DHODH axis (mitochondrial defense in select contexts): DHODH connects pyrimidine synthesis to mitochondrial CoQ reduction, and in some settings, DHODH inhibition has been proposed to heighten ferroptosis sensitivity, especially in GPX4-low states
a label is associated with a container when it is present within a receptacle or carrier that also holds the container, e.g., as a package insert
Walk CL, Alleno C, Bouvet R, Thoby JM, Eising I, Segobola P
Both Douglas Labs and Pure Encapsulations are Emerson Quality Program Gold Partner meaning their sourcing of materials, manufacturing, and production of supplements is in the tier in the industry